These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20533894)

  • 21. Progress towards novel adenosine receptor therapeutics gleaned from the recent patent literature.
    Press NJ; Fozard JR
    Expert Opin Ther Pat; 2010 Aug; 20(8):987-1005. PubMed ID: 20649373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists.
    Cascieri MA; Shiao LL; Mills SG; MacCoss M; Swain CJ; Yu H; Ber E; Sadowski S; Wu MT; Strader CD
    Mol Pharmacol; 1995 Apr; 47(4):660-5. PubMed ID: 7536886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptor.
    Perrine SA; Beard DJ; Young JK; Simmons MA
    Eur J Pharmacol; 2008 Sep; 592(1-3):1-6. PubMed ID: 18634782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and biological characterization of (2R,4S)-1'-acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2-methylphenyl)-N-methyl-4,4'-bipiperidine-1-carboxamide as a new potent and selective neurokinin 1 (NK1) receptor antagonist clinical candidate.
    Di Fabio R; Alvaro G; Griffante C; Pizzi DA; Donati D; Mattioli M; Cimarosti Z; Guercio G; Marchioro C; Provera S; Zonzini L; Montanari D; Melotto S; Gerrard PA; Trist DG; Ratti E; Corsi M
    J Med Chem; 2011 Feb; 54(4):1071-9. PubMed ID: 21229983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Casopitant, a neurokinin-1 receptor antagonist with anti-emetic and anti-nausea activities.
    Navari RM
    Curr Opin Investig Drugs; 2008 Jul; 9(7):774-85. PubMed ID: 18600583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Carides G; Elmer M; Schmidt C; Evans JK; Horgan KJ
    J Clin Oncol; 2003 Nov; 21(22):4105-11. PubMed ID: 14559891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT(7) receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009).
    Leopoldo M; Lacivita E; Berardi F; Perrone R
    Expert Opin Ther Pat; 2010 Jun; 20(6):739-54. PubMed ID: 20476847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Conformational analysis of peptide antagonists in the design of pseudopeptide and non-peptide antagonists].
    Goldstein S; Neuwels M; Lassoie MA; Houssin R; Caumont K; Differding E; Henichart JP
    J Pharm Belg; 1995; 50(2-3):213-22. PubMed ID: 7545749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonists at the neurokinin receptors--recent patent literature.
    Giardina GA; Gagliardi S; Martinelli M
    IDrugs; 2003 Aug; 6(8):758-72. PubMed ID: 12917772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
    Gan TJ; Apfel CC; Kovac A; Philip BK; Singla N; Minkowitz H; Habib AS; Knighton J; Carides AD; Zhang H; Horgan KJ; Evans JK; Lawson FC;
    Anesth Analg; 2007 May; 104(5):1082-9, tables of contents. PubMed ID: 17456656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of palonosetron: emerging data distinguishing it as a novel 5-HT(3) receptor antagonist for chemotherapy-induced nausea and vomiting.
    Saito M; Tsukuda M
    Expert Opin Pharmacother; 2010 Apr; 11(6):1003-14. PubMed ID: 20307224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic study of substance P analogs. II. Rapid screening of 512 substance P stereoisomers for binding to NK1 receptor.
    Wang JX; Dipasquale AJ; Bray AM; Maeji NJ; Spellmeyer DC; Geysen HM
    Int J Pept Protein Res; 1993 Oct; 42(4):392-9. PubMed ID: 7503964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel GABA(B) receptor positive modulators: a patent survey.
    Froestl W
    Expert Opin Ther Pat; 2010 Aug; 20(8):1007-17. PubMed ID: 20645682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging substance P receptors (NK1) in the living human brain using positron emission tomography.
    Hargreaves R
    J Clin Psychiatry; 2002; 63 Suppl 11():18-24. PubMed ID: 12562139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of substance P in the cardiovascular system.
    Mistrova E; Kruzliak P; Chottova Dvorakova M
    Neuropeptides; 2016 Aug; 58():41-51. PubMed ID: 26706184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor.
    Gether U; Johansen TE; Snider RM; Lowe JA; Emonds-Alt X; Yokota Y; Nakanishi S; Schwartz TW
    Regul Pept; 1993 Jul; 46(1-2):49-58. PubMed ID: 7692567
    [No Abstract]   [Full Text] [Related]  

  • 37. Crystal structure of the human NK
    Yin J; Chapman K; Clark LD; Shao Z; Borek D; Xu Q; Wang J; Rosenbaum DM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13264-13269. PubMed ID: 30538204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Farnesoid X receptor modulators: a patent review.
    Crawley ML
    Expert Opin Ther Pat; 2010 Aug; 20(8):1047-57. PubMed ID: 20569093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological and Pharmacological Aspects of the NK1-Receptor.
    Garcia-Recio S; Gascón P
    Biomed Res Int; 2015; 2015():495704. PubMed ID: 26421291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model.
    Evers A; Klebe G
    J Med Chem; 2004 Oct; 47(22):5381-92. PubMed ID: 15481976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.